🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate (i) safety of etanercept in patients with moderate to severe psori...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00581165
Treatments Being Tested
This study involves Rheumatoid Arthritis patients in regular clinical setti...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-01
Trial ID
NCT00858780
Treatments Being Tested
This study aims to demonstrate pharmacokinetic (PK) similarity of biosimila...
Status
Completed
Location
Orchidpharmed PK/PD site
Start Date
2016-12-04
Trial ID
NCT03273088
Treatments Being Tested
With the new reimbursement criteria, we want: To describe the average trea...
Status
Completed
Location
Herestraat 49
Start Date
2011-09
Trial ID
NCT01557283
Treatments Being Tested
Rheumatoid arthritis (RA) is a debilitating chronic immune mediated inflamm...
Status
Unknown
Location
University Hopsital Birmingham NHS Foundation Trust
Start Date
2007-09
Trial ID
NCT00523692
Treatments Being Tested
To compare the efficacy of ETN 50mg twice weekly for 12 weeks followed by r...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-07
Trial ID
NCT00936065
Treatments Being Tested
Studying the effects of Etanercept (an anti-Tumor Necrosis Factor alpha) on...
Status
Withdrawn
Location
Stanford University
Start Date
2014-06
Trial ID
NCT02031211
Treatments Being Tested
The primary purpose of this study is to evaluate the safety and efficacy of...
Status
Completed
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT00418717
Treatments Being Tested
This is a randomized, double-blind, multicentral clinical trial to investig...
Status
Unknown
Location
Chinese Academy of Medical Sciences & Peking Union Medical College
Start Date
2015-01
Trial ID
NCT02701205
Treatments Being Tested
Defining Which Remission Criterion at Month 6 Predicts Remission at Month 1...
Status
Completed
Location
CHU Dinant Godinne
Start Date
2014-08-12
Trial ID
NCT02202837
Treatments Being Tested